Global varicella vaccination programs.
Young Hwa Lee1, Young June Choe1, Jia Lee2
1Department of Pediatrics, Korea University Anam Hospital, Seoul, Korea.
Clinical and Experimental Pediatrics
|December 2, 2022
Summary
This study reviews global varicella vaccination policies to inform national strategies. It highlights the need for country-specific varicella vaccine effectiveness evaluations and optimized schedules.
Area of Science:
- Immunology
- Public Health
- Epidemiology
Background:
- Varicella (chickenpox) is highly contagious, caused by the varicella zoster virus.
- A secondary attack rate exceeds 90%, emphasizing the need for effective control measures.
- Increasing global adoption of universal varicella vaccination programs is observed.
Purpose of the Study:
- To review international varicella vaccination programs and policies.
- To establish a foundation for a national varicella vaccine policy.
- To address the need for optimized vaccination strategies based on local epidemiology and resources.
Main Methods:
- Review of vaccination programs in countries with universal varicella vaccination.
- Analysis of vaccine efficacy and effectiveness data across different programs.
- Assessment of the necessity for national-level varicella vaccine effectiveness evaluation.
Main Results:
- Many countries are implementing 2-dose varicella vaccinations universally.
- Vaccine efficacy and effectiveness vary by vaccine type and program.
- Current varicella vaccine effectiveness evaluation in Korea is short-term and fragmented.
Conclusions:
- Optimized varicella vaccination strategies are required, tailored to national epidemiology and health resources.
- Evaluating varicella vaccine effectiveness in diverse settings is crucial.
- National-level effectiveness studies are necessary to determine optimal varicella vaccination schedules in Korea.
Related Concept Videos
Vaccinations
45.2K
Overview
45.2K
Cancer Vaccines
482
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
482
Preventive Healthcare Services
1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Cross-reactivity
31.4K
Overview
31.4K
Development of Immunocompetence
414
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
414


